# Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension (PARADISE-HTN-II)

> **NCT06018493** · NA · COMPLETED · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 79 (actual)

## Conditions studied

- Hypertension
- Blood Pressure
- Cardiovascular Diseases

## Interventions

- **DEVICE:** focused power ultrasound mediate inferior perirenal adipose tissue modification
- **DEVICE:** sham-control group

## Key facts

- **NCT ID:** NCT06018493
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-01
- **Primary completion:** 2025-02-12
- **Final completion:** 2025-04-20
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06018493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06018493, "Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension (PARADISE-HTN-II)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06018493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*